Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3067% below fair value
$26.23−0.87 (-3.21%)
Close on Nov 19, 2026Market cap $1.51BP/E –Yield –
Enovis revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Enovis's revenue for the twelve months ending Jul 3, 2026 was $2.30B, up 4.9% year over year. For fiscal 2025 it was $2.25B, up 6.7% from the year before. Over ten years it grew -4.1% a year on average. The highest annual figure on record is $4.62B in fiscal 2014.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.25B | +6.7% |
| FY2024 | Dec 31, 2024 | $2.11B | +23.5% |
| FY2023 | Dec 31, 2023 | $1.71B | +9.2% |
| FY2022 | Dec 31, 2022 | $1.56B | +9.6% |
| FY2021 | Dec 31, 2021 | $1.43B | +27.3% |
| FY2020 | Dec 31, 2020 | $1.12B | -66.3% |
| FY2019 | Dec 31, 2019 | $3.33B | +51.7% |
| FY2018 | Dec 31, 2018 | $2.19B | +13.2% |
| FY2017 | Dec 31, 2017 | $1.94B | -39.2% |
| FY2016 | Dec 31, 2016 | $3.19B | -7.2% |
| FY2015 | Dec 31, 2015 | $3.43B | -25.7% |
| FY2014 | Dec 31, 2014 | $4.62B | +9.9% |
| FY2013 | Dec 31, 2013 | $4.21B | +7.5% |
| FY2012 | Dec 31, 2012 | $3.91B | +464.5% |
| FY2011 | Dec 31, 2011 | $693.39M | +27.9% |
| FY2010 | Dec 31, 2010 | $541.99M | +3.2% |
| FY2009 | Dec 31, 2009 | $525.02M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $582.78M | +3.2% |
| Q1 FY2026 | Apr 3, 2026 | $589.15M | +5.4% |
| Q4 FY2025 | Dec 31, 2025 | $575.76M | +2.6% |
| Q3 FY2025 | Oct 3, 2025 | $548.91M | +8.6% |
| Q2 FY2025 | Jul 4, 2025 | $564.55M | +7.5% |
| Q1 FY2025 | Apr 4, 2025 | $558.83M | +8.2% |
| Q4 FY2024 | Dec 31, 2024 | $560.98M | +23.3% |
| Q3 FY2024 | Sep 27, 2024 | $505.22M | +21.0% |
| Q2 FY2024 | Jun 28, 2024 | $525.16M | +22.6% |
| Q1 FY2024 | Mar 29, 2024 | $516.27M | +27.1% |
| Q4 FY2023 | Dec 31, 2023 | $455.02M | +11.3% |
| Q3 FY2023 | Sep 29, 2023 | $417.52M | +8.8% |
| Q2 FY2023 | Jun 30, 2023 | $428.50M | +8.4% |
| Q1 FY2023 | Mar 31, 2023 | $406.15M | +8.2% |
| Q4 FY2022 | Dec 31, 2022 | $408.71M | +2.4% |
| Q3 FY2022 | Sep 30, 2022 | $383.81M | +6.6% |
| Q2 FY2022 | Jul 1, 2022 | $395.12M | +10.9% |
| Q1 FY2022 | Apr 1, 2022 | $375.46M | +20.7% |
| Q4 FY2021 | Dec 31, 2021 | $399.06M | -51.8% |
| Q3 FY2021 | Oct 1, 2021 | $359.92M | -55.3% |
| Q2 FY2021 | Jul 2, 2021 | $356.12M | -42.6% |
| Q1 FY2021 | Apr 2, 2021 | $311.08M | -61.9% |
| Q4 FY2020 | Dec 31, 2020 | $828.12M | -6.8% |
| Q3 FY2020 | Oct 2, 2020 | $805.93M | -4.8% |
| Q2 FY2020 | Jul 3, 2020 | $620.36M | -31.7% |
| Q1 FY2020 | Apr 3, 2020 | $816.36M | +19.4% |
| Q4 FY2019 | Dec 31, 2019 | $888.37M | +54.5% |
| Q3 FY2019 | Sep 27, 2019 | $846.52M | +61.5% |
| Q2 FY2019 | Jun 28, 2019 | $908.65M | +62.0% |
| Q1 FY2019 | Mar 29, 2019 | $683.92M | +28.2% |
| Q4 FY2018 | Dec 31, 2018 | $574.93M | -34.2% |
| Q3 FY2018 | Sep 28, 2018 | $524.02M | -37.9% |
| Q2 FY2018 | Jun 29, 2018 | $560.86M | -33.9% |
| Q1 FY2018 | Mar 31, 2018 | $533.27M | -27.3% |
| Q4 FY2017 | Dec 31, 2017 | $874.08M | +7.6% |
| Q3 FY2017 | Sep 29, 2017 | $844.51M | +10.2% |
| Q2 FY2017 | Jun 30, 2017 | $847.96M | – |
| Q1 FY2017 | Mar 31, 2017 | $733.63M | – |
| Q4 FY2016 | Dec 31, 2016 | $812.41M | – |
| Q3 FY2016 | Sep 30, 2016 | $766.52M | – |
See a number that looks wrong?